Does LOPINAVIR Cause Lipodystrophy acquired? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Lipodystrophy acquired have been filed in association with LOPINAVIR (Kaletra). This represents 10.1% of all adverse event reports for LOPINAVIR.
126
Reports of Lipodystrophy acquired with LOPINAVIR
10.1%
of all LOPINAVIR reports
1
Deaths
1
Hospitalizations
How Dangerous Is Lipodystrophy acquired From LOPINAVIR?
Of the 126 reports, 1 (0.8%) resulted in death, 1 (0.8%) required hospitalization.
Is Lipodystrophy acquired Listed in the Official Label?
Yes, Lipodystrophy acquired is listed as a known adverse reaction in the official FDA drug label for LOPINAVIR.
What Other Side Effects Does LOPINAVIR Cause?
Foetal exposure during pregnancy (244)
Exposure during pregnancy (184)
Virologic failure (170)
Drug resistance (134)
Off label use (133)
Premature baby (107)
Diplopia (89)
Treatment failure (89)
Premature delivery (88)
Eyelid ptosis (87)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
Which LOPINAVIR Alternatives Have Lower Lipodystrophy acquired Risk?
LOPINAVIR vs LOPINAVIR\RITONAVIR
LOPINAVIR vs LOPRAZOLAM
LOPINAVIR vs LORATADINE
LOPINAVIR vs LORATADINE\PSEUDOEPHEDRINE
LOPINAVIR vs LORAZEPAM